Quince Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $168 |
Gross Profit | -36 | -35 | -32 | -16 |
EBITDA | -13,452 | -15,947 | -12,902 | -12,435 |
EBIT | -13,488 | -15,982 | -12,934 | -12,451 |
Net Income | -13,442 | -16,049 | -15,030 | -12,458 |
Net Change In Cash | 0 | 0 | 0 | 168 |
Free Cash Flow | -10,002 | -11,541 | -9,749 | -7,685 |
Cash | 6,452 | 16,826 | 7,771 | 6,212 |
Basic Shares | 53,951 | 46,686 | 43,941 | 43,262 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -186 | -322 | -175 | -344 |
EBITDA | -35,984 | -26,820 | -50,986 | -89,974 |
EBIT | -36,170 | -27,142 | -51,190 | -90,318 |
Net Income | -56,828 | -31,385 | -51,660 | -89,945 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,329 | |||
Free Cash Flow | -32,161 | -18,452 | -44,171 | -63,112 |
Cash | 6,212 | 20,752 | 44,579 | 69,724 |
Basic Shares | 43,262 | 37,237 | 33,496 | 29,718 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.25 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.34 |
2024-12-31 | -$0.28 |
